Wallingford, CT, United States of America

Robert G Gentles

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 6.8

ph-index = 8

Forward Citations = 229(Granted Patents)


Location History:

  • Wallingford, CT (US) (2006 - 2019)
  • Killingworth, CT (US) (2018 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Innovations by Robert G. Gentles in T Cell Activation

Introduction

Robert G. Gentles, based in Wallingford, CT, is a notable inventor with a remarkable portfolio of 27 patents. His work primarily revolves around the development of novel compounds that contribute significantly to medical advancements, particularly in the treatment of viral infections and proliferative disorders such as cancer.

Latest Patents

Gentles' latest patents include innovative naphthyridinone compounds that serve as T cell activators. One such patent describes compounds of a specific formula, detailing various substitutions and their pharmacological implications. These compounds are designed to inhibit the activity of diacylglycerol kinase alpha (DGKα) and diacylglycerol kinase zeta (DGKζ), offering new avenues for the treatment of serious health conditions, including viral infections and cancer. His advancements in this area underscore the potential of these compounds in enhancing immune response and therapeutic effect in complex diseases.

Career Highlights

Throughout his career, Robert has made significant contributions while working with prominent organizations such as Bristol-Myers Squibb Company and ViiV Healthcare UK (No.5) Limited. His expertise and innovative approach have established him as a key player in the pharmaceutical field, particularly in the realms of immunology and oncology.

Collaborations

Gentles has collaborated with notable co-workers, including Min Ding and Xiaofan Zheng. Together, they have worked on groundbreaking research that amplifies the understanding and application of T cell activation and its role in therapeutics. Such collaborations emphasize the importance of teamwork in driving scientific innovations.

Conclusion

Robert G. Gentles' contributions to the field of medical science through his inventions and patents are invaluable. His work on naphthyridinone compounds not only reflects his innovative spirit but also promises to enhance treatment strategies for various diseases. As research continues to evolve, his patents will likely pave the way for new therapeutic options in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…